| Program Director |
Type of Grant / Project
Description |
|
Addie Corradi
Beth Israel Medical
Center
First Avenue & 16th Street
New York, NY
10003
|
CSAT Targeted Capacity Expansion/SAT
Grant
The applicant’s methadone maintenance treatment program
proposes to establish a comprehensive intensive day treatment
program for women only. The proposed program will serve at
risk ethnic minority women by responding to women’s unique
needs and being culturally sensitive. On site services will
include methadone maintenance, drug counseling, HIV testing
and counseling, counseling for sexual abuse, domestic
violence, and negotiating safer sex, and workshops on
parenting, employment skills, and life skills
training. |
Robert Carey
Central NY Research Corporation
800 Irving Ave.
Syracuse, NY 13210 |
NIDA
Project Interoceptive Drug Cue Conditioning of Cocaine Effects
The overall objective of this proposal is to investigate
interoceptive drug cue conditioning of cocaine stimulant
effects. This research is important for the identification of
the ways interoceptive drug cues can activate or inactivate
cocaine conditioned stimuli.
Date
Started: 30-Sep-99 Date
Ends: 31-Aug-03 |
Adam Bisaga
Columbia University Health Sciences
OGC
New York, NY 10032 |
NIDA
Project Evaluation of NMDA Antagonist for Opiate Dependence
This application for a mentored research career award aims to
enhance research skills of principal investigator by focusing
on a systematic laboratory and clinical evaluation of
memantine, an NMDA antagonist, for the treatment of opid
dependence. Two aspects of pharmacotherapy will be addressed:
detoxification and relapse prevention. This novel approach to
treatment will initially evaluated using a laboratory model,
and will be followed by a controlled clinical trial.
Date
Started: 1-Sep-99 Date
Ends: 30-Jun-04 |
Eric Collins
Columbia University Health Sciences
OGC
New York, NY 10032 |
NIDA
Project Novel Treatment Strategies for Opioid Dependence
This application for a mentored clinical scientist development
award aims to enhance the developing skills of Eric Collins,
MD, by focusing on several approaches to testing treatment
strategies for opid dependence. The research plan includes the
following: a laboratory study of the effects of naltrexone on
heroin self-administration; double-blind clinical trials
comparing naltrexone precipitated detoxification with
buprenorphine as intermediary detoxification agent for
transition to naltrexone maintenance; and an open trial
combining naltrexone maintenance with relapse
prevention/coping skills
training.
Date
Started: 31-Aug-96 Date
Ends: 31-Aug-01 |
Maria Sullivan
Columbia University Health Sciences
OGC
New York, NY 10032 |
NIDA
Project Opiate & Nicotine Dependence - Medications and
Therapy
No further information is available at this time.
Date
Started: 1-Sep-99 Date
Ends: 30-Jun-04 |
|
Ernest Drucker
Montefiore Medical Center
(Bronx)
111 E 210th St
New York, NY 10467
|
NIDA
Project Office Based Methadone Prescribing
Specialty methadone clinics often separate addiction treatment
from primary care and reproductive health services,
fragmenting medical management and marginalizing the very
syndrome (addiction) that lies at the core of the problem. By
developing the capacity of primary care practitioners and
specialists in women’s health care to treat methadone
patients within their office or health care center practice,
we have the potential to foster greater integration of medical
care and addiction treatment. The proposed study is a
randomized clinical trial in which an office-based
practitioner model for the prescription of methadone is
compared to usual care in a Methadone Maintenance Treatment
Program (MMTP). If successful, office-based methadone
prescribing has the potential to increase the number of
patients cared for and the number of clinicians skilled in
addiction medicine necessary first step toward the ultimate
objective of making methadone treatment more available and
anticipating the changes associated with the introduction of
managed care.
Date
Started: 5-Sep-97 Date
Ends: 31-Jul-00 |
Conor Farren
Mt. Sinai School of Medicine of CUNY
City University of New York
New York, NY 10029 |
NIAAA Project
Sertraline & Naltrexone for Alcohol Dependents
The aim of this double-blind placebo controlled outpatient
trial is to improve the abstinence and relapse rates in
alcohol dependent subjects on naltrexone through the addition
of sertraline, a seretonin reuptake inhibitor. The
investigators hypothesize an increase in abstinence and a
decrease in relapse in the alcohol dependent subjects through
a synergistic effect of the opiate antagonistic and the
serotonin reuptake inhibitor.
Date started 31-Aug-02 Date ends31-Aug-02 |
Marc Galanter
Nathan S. Kline Institute for
Psychiatric Research
Orangesburg, NY 10962 |
NIDA
Project Network Therapy Development, Stage II with
Buprenorphine
This is a Stage II psychosocial development study, combined
with medication. It ensues from our Stage I study entitled
“Development of Network Therapy for Cocaine Abuse. Only a
minority of heroin addicts are enrolled in addiction
treatment, and it is therefore important to develop approaches
to care that will attract the larger, unserved population.
Network Therapy, a comprehensive intensive, standardized,
psychosocial treatment in combination with a pharmacotherapy
regimen may offer one such option, and may also be appropriate
for certain patients in a private medical office setting. The
objective of the present study is to ascertain the relative
effectiveness of Network Therapy and a less intensive level of
behavioral intervention, when each is paired with an identical
regimen of buprenorphine treatment.
Date
Started: 1-Apr-99 Date
Ends: 31-Mar-03 |
Suzette Evans
New York State Psychiatric Institute
1051 Riverside Dr.
New York, NY 10032 |
NIAAA Project
Medications Development for Alcohol Abuse: NMDA Agents
Neurotransmission at NMDA receptors may contribute to many of
alcohol's effects and it is postulated that modulation of NMDA
neurotransmission may be effective in the treatment of alcohol
use disorders. This application represents, to the grantees
knowledge, the first attempt to systematically evaluate the
contribution of NMDA receptor-mediated neurotransmission on
alcohol's action in humans from the perspective of medication
development.
Date started 30-Jun-04 Date ends30-Jun-04 |
Herbert Kleber
New York State Psychiatric Institute
1051 Riverside Dr.
New York, NY 10032 |
NIDA
Project A Study of Anesthesia - Assisted Heroin Detoxification
Detoxification is and will continue to be a common first step
in the treatment of individuals with heroin dependence. During
the past decade, there has been considerable popular attention
focused on the utilization of general anesthesia during the
acute phase of antagonist-percipitated opioid withdrawal, but
there have been no controlled studies of anesthesia-assisted
detoxification techniques. In particular, follow-up data on
patients detoxified under general anesthesia are not
available. The research proposed
here aims to compare anesthesia-assisted rapid opioid
detoxification (AROD) with two alternative detoxification
techniques, with attention both to acute measures of
withdrawal and to longer-term abstinence and compliance with
naltrexone maintenance. We expect to provide information about
the safety and immediate- and intermediate-term efficacy of
anesthesia-assisted detoxification from heroin. We believe
that this information is very important for policy makers and
patients, as anesthesia-assisted detoxification techniques
have proliferated in this country and throughout the world,
exposing patients to the costs and risks of anesthesia,
without any evidence of improved outcome for the
heroin-dependent individuals who choose anesthesia as a means
to detoxification.
Date
Started: 5-Sep-99 Date
Ends: 31-Aug-02 |
Research Page
